{pixabay|100|campaign} What we have in place in Europe already provides an excellent means for bringing products to market. Many would consider the Centralised Procedure, which was first introduced in 1995, the ideal route for approval within Europe. Since 2005 the Centralised Procedure, coordinated successfully by the European Medicines Agency (EMA), is now a valid route…

Read More